Fully quantitative, mass‐standardised, antibody responses to ten SARS‐CoV‐2 variants show significant variation in immunity profiles or endotypes. The incidence of the complete response to all variants is significantly improved after three vaccinations.
Philip H. James‐Pemberton +6 more
wiley +1 more source
Differentiation of COVID-19 from other types of viral pneumonia and severity scoring on baseline chest radiographs: Comparison of deep learning with multi-reader evaluation. [PDF]
Enshaei N +15 more
europepmc +1 more source
Role of viral and bacterial pathogens in causing pneumonia among Western Australian children
Mejbah Bhuiyan
openalex +1 more source
ABSTRACT Aim To develop an in‐depth understanding of peoples' perceptions and experiences of decision‐making and reasons why they declined the opportunity of a kidney transplant. Design The Theory of Planned Behaviour informed the qualitative interpretative phenomenological analysis. Methods Semi‐structured interviews were conducted between August 2022
Emma Jones +3 more
wiley +1 more source
One for All and All for One: Multikingdom Interplay in Severe Viral Pneumonia. [PDF]
Egger M, Hoenigl M.
europepmc +1 more source
A Concept Analysis of Expertise Associated With Practicing Clinical Nurses in Hospital Settings
ABSTRACT Aim Analyse the concept of expertise among practicing clinical nurses in hospital settings. Background The generational loss of expert clinical nurses was exacerbated globally by the novel coronavirus. This ongoing loss combined with the increased complexity of hospitalised patients has prompted an urgent need to understand expertise among ...
Jonathan D. Hecht +4 more
wiley +1 more source
Severe influenza A viral pneumonia in a hemodialysis patient: successful treatment with steroid pulse therapy. [PDF]
Ito H +5 more
europepmc +1 more source
The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui +11 more
wiley +1 more source
Immunocompromise and early-onset invasive pulmonary aspergillosis in viral pneumonia: a retrospective cohort study [PDF]
Borui Sun +6 more
openalex +1 more source

